{
  "schema_version": "0.4",
  "ir_kind": "core",
  "metadata": {
    "title": "Morphogen treatment protocol with concentration gradients",
    "source": {
      "type": "paper_pdf",
      "id": "s41592-025-02927-5.pdf"
    }
  },
  "resources": {
    "materials": [],
    "containers": [],
    "equipment": [],
    "samples": [],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "annotate",
        "params": {
          "note": "Morphogen treatment modalities shown: concentration gradients with darker shading indicating higher concentration; untreated controls marked with 'X'. Timing: early (up) to late (down). Marker genes include POU5F1, TFAP2A, SOX2, STMN2, FOXG1, NKX2-1, VSX2, HOXB2, FOXA2."
        },
        "inputs": [],
        "outputs": []
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s1"
      }
    ],
    "detail_level": 0
  }
}